Humacyte, Inc. (HUMA) Tops Q2 EPS by 57c

Humacyte, Inc. (NASDAQ: HUMA) reported Q2 EPS of $0.35, $0.57 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $235.4 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
• Bernstein: 'Case studies from Microchip and other Semiconductor LTAs - What's different this time?'
• Citi upgrades Knight-Swift and Saia to Buy after trucking stock pullback